81 FR 95644 - Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 81, Issue 249 (December 28, 2016)
Drug Enforcement Administration
Federal Register Volume 81, Issue 249 (December 28, 2016)
| Page Range | 95644-95647 | |
| FR Document | 2016-31285 |
[Federal Register Volume 81, Number 249 (Wednesday, December 28, 2016)] [Notices] [Pages 95644-95647] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-31285] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before February 27, 2017. ADDRESSES: Written comments should be sent to: Drug Enforcement [[Page 95645]] Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated her authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on August 16, 2016, Cayman Chemical Company, 1180 East Ellsworth Road, Ann Arbor, Michigan 48108 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: ------------------------------------------------------------------------ Controlled substance Drug code Schedule ------------------------------------------------------------------------ 3-Fluoro-N-methylcathinone (3-FMC)..... 1233 I Cathinone.............................. 1235 I Methcathinone.......................... 1237 I 4-Fluoro-N-methylcathinone (4-FMC)..... 1238 I Pentedrone ([alpha]- 1246 I methylaminovalerophenone)............. Mephedrone (4-Methyl-N-methylcathinone) 1248 I 4-Methyl-N-ethylcathinone (4-MEC)...... 1249 I Naphyrone.............................. 1258 I N-Ethylamphetamine..................... 1475 I N,N-Dimethylamphetamine................ 1480 I Fenethylline........................... 1503 I Aminorex............................... 1585 I 4-Methylaminorex (cis isomer).......... 1590 I Gamma Hydroxybutyric Acid.............. 2010 I Methaqualone........................... 2565 I Mecloqualone........................... 2572 I JWH-250 (1-Pentyl-3-(2- 6250 I methoxyphenylacetyl) indole).......... SR-18 (Also known as RCS-8) (1- 7008 I Cyclohexylethyl-3-(2- methoxyphenylacetyl) indole).......... 5-Flouro-UR-144 and XLR11 [1-(5-Fluoro- 7011 I pentyl)1H-indol-3-yl](2,2,3,3- tetramethylcyclopropyl)methanone...... AB-FUBINACA (N-(1-amino-3-methyl-1- 7012 I oxobutan-2-yl)-1-(4-fluorobenzyl)-1H- indazole-3-carboxamide)............... JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) 7019 I AB-PINACA (N-(1-amino-3-methyl-1- 7023 I oxobutan-2-yl)-1-pentyl-1H-indazole-.. 3-carboxamide)......................... THJ-2201 [1-(5-fluoropentyl)-1H-indazol- 7024 I 3-.................................... yl](naphthalen-1-yl)methanone.......... AB-CHMINACA (N-(1-amino-3-methyl-1- 7031 I oxobutan-2-yl)-1-(cyclohexylmethyl)-.. 1H-indazole-3-carboxamide.............. MAB-CHMINACA (N-(1-amino-3,3dimethyl-1- 7032 I oxobutan-2-yl)-1-(cyclohexylmethyl)-1H- indazole-3-carboxamide)............... ADB-PINACA (N-(1-amino-3,3-dimethyl-1- 7035 I oxobutan-2-yl)-1-pentyl-1H-indazole-3- carboxamide).......................... APINACA and AKB48 N-(1-Adamantyl)-1- 7048 I pentyl-1H-indazole-3-carboxamide...... JWH-081 (1-Pentyl-3-(1-(4- 7081 I methoxynaphthoyl) indole)............. SR-19 (Also known as RCS-4) (1-Pentyl-3- 7104 I [(4-methoxy)-benzoyl] indole.......... JWH-018 (also known as AM678) (1-Pentyl- 7118 I 3-(1-naphthoyl)indole)................ JWH-122 (1-Pentyl-3-(4-methyl-1- 7122 I naphthoyl) indole).................... UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- 7144 I tetramethylcyclopropyl)methanone...... JWH-073 (1-Butyl-3-(1-naphthoyl)indole) 7173 I JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3- 7200 I (1-naphthoyl)indole).................. AM2201 (1-(5-Fluoropentyl)-3-(1- 7201 I naphthoyl) indole).................... JWH-203 (1-Pentyl-3-(2- 7203 I chlorophenylacetyl) indole)........... PB-22 (Quinolin-8-yl 1-pentyl-1H-indole- 7222 I 3-carboxylate)........................ 5F-PB-22 (Quinolin-8-yl 1-(5- 7225 I fluoropentyl)-1H-indole-3-carboxylate) Alpha-ethyltryptamine.................. 7249 I Ibogaine............................... 7260 I CP-47,497 (5-(1,1-Dimethylheptyl)-2- 7297 I [(1R,3S)-3-hydroxycyclohexyl-phenol).. CP-47,497 C8 Homologue (5-(1,1- 7298 I Dimethyloctyl)-2-[(1R,3S)3- hydroxycyclohexyl-phenol)............. Lysergic acid diethylamide............. 7315 I 2,5-Dimethoxy-4-(n)- 7348 I propylthiophenethylamine (2C-T-7)..... Marihuana.............................. 7360 I Tetrahydrocannabinols.................. 7370 I Mescaline.............................. 7381 I 2-(4-Ethylthio-2,5-dimethoxyphenyl) 7385 I ethanamine (2C-T-2 ).................. 3,4,5-Trimethoxyamphetamine............ 7390 I 4-Bromo-2,5-dimethoxyamphetamine....... 7391 I 4-Bromo-2,5-dimethoxyphenethylamine.... 7392 I 4-Methyl-2,5-dimethoxyamphetamine...... 7395 I 2,5-Dimethoxyamphetamine............... 7396 I JWH-398 (1-Pentyl-3-(4-chloro-1- 7398 I naphthoyl) indole).................... 2,5-Dimethoxy-4-ethylamphetamine....... 7399 I 3,4-Methylenedioxyamphetamine.......... 7400 I 5-Methoxy-3,4-methylenedioxyamphetamine 7401 I N-Hydroxy-3,4-methylenedioxyamphetamine 7402 I [[Page 95646]] 3,4-Methylenedioxy-N-ethylamphetamine.. 7404 I 3,4-Methylenedioxymethamphetamine...... 7405 I 4-Methoxyamphetamine................... 7411 I 5-Methoxy-N-N-dimethyltryptamine....... 7431 I Alpha-methyltryptamine................. 7432 I Bufotenine............................. 7433 I Diethyltryptamine...................... 7434 I Dimethyltryptamine..................... 7435 I Psilocybin............................. 7437 I Psilocyn............................... 7438 I 5-Methoxy-N,N-diisopropyltryptamine.... 7439 I N-Benzylpiperazine..................... 7493 I 2-(2,5-Dimethoxy-4-methylphenyl) 7508 I ethanamine (2C-D)..................... 2-(2,5-Dimethoxy-4-ethylphenyl) 7509 I ethanamine (2C-E ).................... 2-(2,5-Dimethoxyphenyl) ethanamine (2C- 7517 I H).................................... 2-(4-Iodo-2,5-dimethoxyphenyl) 7518 I ethanamine (2C-I)..................... 2-(4-Chloro-2,5-dimethoxyphenyl) 7519 I ethanamine (2C-C)..................... 2-(2,5-Dimethoxy-4-nitro-phenyl) 7521 I ethanamine (2C-N)..................... 2-(2,5-Dimethoxy-4-(n)-propylphenyl) 7524 I ethanamine (2C-P)..................... 2-(4-Isopropylthio)-2,5- 7532 I dimethoxyphenyl) ethanamine (2C-T-4 ). MDPV (3,4-Methylenedioxypyrovalerone).. 7535 I 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2- 7536 I methoxybenzyl) ethanamine (25B-NBOMe). 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2- 7537 I methoxybenzyl) ethanamine (25C-NBOMe). 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2- 7538 I methoxybenzyl) ethanamine (25I-NBOMe). Methylone (3,4-Methylenedioxy-N- 7540 I methylcathinone)...................... Butylone............................... 7541 I Pentylone.............................. 7542 I alpha-pyrrolidinopentiophenone ([alpha]- 7545 I PVP).................................. alpha-pyrrolidinobutiophenone ([alpha]- 7546 I PBP).................................. AM-694 (1-(5-Fluoropentyl)-3-(2- 7694 I iodobenzoyl) indole).................. Acetyldihydrocodeine................... 9051 I Benzylmorphine......................... 9052 I Codeine-N-oxide........................ 9053 I Desomorphine........................... 9055 I Etorphine (except HCl)................. 9056 I Codeine methylbromide.................. 9070 I Dihydromorphine........................ 9145 I Heroin................................. 9200 I Morphine-N-oxide....................... 9307 I Normorphine............................ 9313 I Tilidine............................... 9750 I Para-Fluorofentanyl.................... 9812 I 3-Methylfentanyl....................... 9813 I Alpha-methylfentanyl................... 9814 I Acetyl-alpha-methylfentanyl............ 9815 I Acetyl Fentanyl (N-(1- 9821 I phenethylpiperidin-4-yl)-N- phenylacetamide)...................... Butyryl Fentanyl....................... 9822 I Beta-hydroxyfentanyl................... 9830 I Beta-hydroxy-3-methylfentanyl.......... 9831 I 3-Methylthiofentanyl................... 9833 I Thiofentanyl........................... 9835 I Beta-hydroxythiofentanyl............... 9836 I Amphetamine............................ 1100 II Methamphetamine........................ 1105 II Lisdexamfetamine....................... 1205 II Phenmetrazine.......................... 1631 II Methylphenidate........................ 1724 II Amobarbital............................ 2125 II Pentobarbital.......................... 2270 II Secobarbital........................... 2315 II Phencyclidine.......................... 7471 II Phenylacetone.......................... 8501 II Cocaine................................ 9041 II Codeine................................ 9050 II Etorphine HCl.......................... 9059 II Dihydrocodeine......................... 9120 II Oxycodone.............................. 9143 II Hydromorphone.......................... 9150 II Ecgonine............................... 9180 II Ethylmorphine.......................... 9190 II Hydrocodone............................ 9193 II Levomethorphan......................... 9210 II Levorphanol............................ 9220 II Isomethadone........................... 9226 II [[Page 95647]] Meperidine............................. 9230 II Meperidine intermediate-B.............. 9233 II Methadone.............................. 9250 II Dextropropoxyphene, bulk (non-dosage 9273 II forms)................................ Morphine............................... 9300 II Thebaine............................... 9333 II Oxymorphone............................ 9652 II Alfentanil............................. 9737 II Remifentanil........................... 9739 II Sufentanil............................. 9740 II Carfentanil............................ 9743 II Tapentadol............................. 9780 II Fentanyl............................... 9801 II ------------------------------------------------------------------------ The company plans to manufacture bulk controlled substances for use in product development of analytical reference standards, for distribution to its customers. Dated: December 20, 2016. Louis J. Milione, Assistant Administrator. [FR Doc. 2016-31285 Filed 12-27-16; 8:45 am] BILLING CODE 4410-09-P
![95644 Federal Register / Vol. 81, No. 249 / Wednesday, December 28, 2016 / Notices
Controlled substance Drug code Schedule
Carfentanil ....................................................................................................................................................................... 9743 II
Tapentadol ....................................................................................................................................................................... 9780 II
Fentanyl ........................................................................................................................................................................... 9801 II
The company plans to manufacture September 1, 2016, Cambridge Isotope authority under the Controlled
the above-listed controlled substances Laboratories, Inc., 50 Frontage Road, Substances Act to the Administrator of
in bulk for distribution to its customers. Andover, Massachusetts 01810 applied the Drug Enforcement Administration
In reference to drug codes 7360 to be registered as a bulk manufacturer (DEA), 28 CFR 0.100(b). Authority to
marihuana and 7370 of morphine (9300), a basic class of exercise all necessary functions with
tetrahydrocannabinols the company controlled substance listed in schedule respect to the promulgation and
plans to bulk manufacture both as II: implementation of 21 CFR part 1301,
synthetic substances. No other activity The company plans to utilize small incident to the registration of
for these drug codes is authorized for quantities of the listed controlled manufacturers, distributors, dispensers
this registration. substance for use in product importers, and exporters of controlled
Dated: December 19, 2016. development of analytical reference substances (other than final orders in
Louis J. Milione, standards, for distribution to its connection with suspension, denial, or
customers. revocation of registration) has been
Assistant Administrator.
Dated: December 19, 2016. redelegated to the Assistant
[FR Doc. 2016–31279 Filed 12–27–16; 8:45 am]
Louis J. Milione,
Administrator of the DEA Diversion
BILLING CODE 4410–09–P
Control Division (‘‘Assistant
Assistant Administrator.
Administrator’’) pursuant to section 7 of
[FR Doc. 2016–31271 Filed 12–27–16; 8:45 am]
28 CFR part 0, appendix to subpart R.
DEPARTMENT OF JUSTICE BILLING CODE 4410–09–P In accordance with 21 CFR
[Docket No. DEA–392] 1301.34(a), this is notice that on
September 20, 2016, Wildlife
Bulk Manufacturer of Controlled DEPARTMENT OF JUSTICE Laboratories, Inc., 1230 W. Ash Street,
Substances Application: Cambridge Suite D, Windsor, Colorado 80550–8055
Isotope Laboratories Drug Enforcement Administration
applied to be registered as an importer
[Docket No. DEA–392] of the following basic class of controlled
ACTION: Notice of application.
substances.
Importer of Controlled Substances
DATES: Registered bulk manufacturers of Application: Wildlife Laboratories, Inc. Drug
the affected basic classes, and Controlled substance code Schedule
applicants therefore, may file written ACTION: Notice of application.
comments on or objections to the Thiafentanil ............... 9729 II
issuance of the proposed registration in DATES: Registered bulk manufacturers of
accordance with 21 CFR 1301.33(a) on the affected basic classes, and The company plans to import the
or before February 27, 2017. applicants therefore, may file written listed controlled substance for sale to its
ADDRESSES: Written comments should comments on or objections to the customers.
be sent to: Drug Enforcement issuance of the proposed registration in Dated: December 20, 2016.
Administration, Attention: DEA Federal accordance with 21 CFR 1301.34(a) on
Louis J. Milione,
Register Representative/DRW, 8701 or before January 27, 2017. Such
Assistant Administrator.
Morrissette Drive, Springfield, Virginia persons may also file a written request
[FR Doc. 2016–31272 Filed 12–27–16; 8:45 am]
22152. for a hearing on the application
pursuant to 21 CFR 1301.43 on or before BILLING CODE 4410–09–P
SUPPLEMENTARY INFORMATION: The
January 27, 2017.
Attorney General has delegated her
authority under the Controlled ADDRESSES: Written comments should
DEPARTMENT OF JUSTICE
Substances Act to the Administrator of be sent to: Drug Enforcement
the Drug Enforcement Administration Administration, Attention: DEA Federal Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia [Docket No. DEA–392]
exercise all necessary functions with
respect to the promulgation and 22152. All requests for hearing must be Bulk Manufacturer of Controlled
implementation of 21 CFR part 1301, sent to: Drug Enforcement Substances Application: Cayman
incident to the registration of Administration, Attn: Administrator, Chemical Company
manufacturers, distributors, dispensers, 8701 Morrissette Drive, Springfield,
importers, and exporters of controlled Virginia 22152. All requests for hearing ACTION: Notice of application.
substances (other than final orders in should also be sent to: (1) Drug
connection with suspension, denial, or Enforcement Administration, Attn: DATES: Registered bulk manufacturers of
Hearing Clerk/LJ, 8701 Morrissette the affected basic classes, and
sradovich on DSK3GMQ082PROD with NOTICES
revocation of registration) has been
redelegated to the Assistant Drive, Springfield, Virginia 22152; and applicants therefore, may file written
Administrator of the DEA Diversion (2) Drug Enforcement Administration, comments on or objections to the
Control Division (‘‘Assistant Attn: DEA Federal Register issuance of the proposed registration in
Administrator’’) pursuant to section 7 of Representative/DRW, 8701 Morrissette accordance with 21 CFR 1301.33(a) on
28 CFR part 0, appendix to subpart R. Drive, Springfield, Virginia 22152. or before February 27, 2017.
In accordance with 21 CFR SUPPLEMENTARY INFORMATION: The ADDRESSES: Written comments should
1301.34(a), this is notice that on Attorney General has delegated her be sent to: Drug Enforcement
VerDate Sep<11>2014 18:54 Dec 27, 2016 Jkt 241001 PO 00000 Frm 00090 Fmt 4703 Sfmt 4703 E:\FR\FM\28DEN1.SGM 28DEN1](https://thefederalregister.org/doc/81_FR_95893/page/1.svg)
methanone ......... 7011 I.
AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ............. 7012 I.
JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) .............................................................................................................. 7019 I.
AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole- ..........................................................
3-carboxamide) ........................................................................................................................................................ 7023 I.
THJ–2201 [1-(5-fluoropentyl)-1H-indazol-3- ............................................................................................................
yl](naphthalen-1-yl)methanone ................................................................................................................................ 7024 I.
AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)- .....................................................
1H-indazole-3-carboxamide ..................................................................................................................................... 7031 I.
MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) 7032 I.
ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ......................... 7035 I.
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide ....................................................... 7048 I.
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) .......................................................................................... 7081 I.
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ............................................................ 7104 I.
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ...................................................................... 7118 I.
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ............................................................................................. 7122 I.
UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ......................................................... 7144 I.
JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ............................................................................................................... 7173 I.
JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) .................................................................................. 7200 I.
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ............................................................................................... 7201 I.
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) .............................................................................................. 7203 I.
PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ......................................................................................... 7222 I.
5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) .................................................................... 7225 I.
Alpha-ethyltryptamine .............................................................................................................................................. 7249 I.
Ibogaine ................................................................................................................................................................... 7260 I.
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ......................................................... 7297 I.
CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ................................... 7298 I.
Lysergic acid diethylamide ...................................................................................................................................... 7315 I.
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) ...................................................................................... 7348 I.
Marihuana ................................................................................................................................................................ 7360 I.
Tetrahydrocannabinols ............................................................................................................................................ 7370 I.
Mescaline ................................................................................................................................................................. 7381 I.
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2 ) .................................................................................. 7385 I.
3,4,5-Trimethoxyamphetamine ................................................................................................................................ 7390 I.
4-Bromo-2,5-dimethoxyamphetamine ...................................................................................................................... 7391 I.
sradovich on DSK3GMQ082PROD with NOTICES
4-Bromo-2,5-dimethoxyphenethylamine .................................................................................................................. 7392 I.
4-Methyl-2,5-dimethoxyamphetamine ...................................................................................................................... 7395 I.
2,5-Dimethoxyamphetamine .................................................................................................................................... 7396 I.
JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) .............................................................................................. 7398 I.
2,5-Dimethoxy-4-ethylamphetamine ........................................................................................................................ 7399 I.
3,4-Methylenedioxyamphetamine ............................................................................................................................ 7400 I.
5-Methoxy-3,4-methylenedioxyamphetamine .......................................................................................................... 7401 I.
N-Hydroxy-3,4-methylenedioxyamphetamine .......................................................................................................... 7402 I.
VerDate Sep<11>2014 18:54 Dec 27, 2016 Jkt 241001 PO 00000 Frm 00091 Fmt 4703 Sfmt 4703 E:\FR\FM\28DEN1.SGM 28DEN1](https://thefederalregister.org/doc/81_FR_95893/page/2.svg)
![Federal Register / Vol. 81, No. 249 / Wednesday, December 28, 2016 / Notices 95647
Controlled substance Drug code Schedule
Meperidine ............................................................................................................................................................... 9230 II.
Meperidine intermediate-B ....................................................................................................................................... 9233 II.
Methadone ............................................................................................................................................................... 9250 II.
Dextropropoxyphene, bulk (non-dosage forms) ...................................................................................................... 9273 II.
Morphine .................................................................................................................................................................. 9300 II.
Thebaine .................................................................................................................................................................. 9333 II.
Oxymorphone .......................................................................................................................................................... 9652 II.
Alfentanil .................................................................................................................................................................. 9737 II.
Remifentanil ............................................................................................................................................................. 9739 II.
Sufentanil ................................................................................................................................................................. 9740 II.
Carfentanil ................................................................................................................................................................ 9743 II.
Tapentadol ............................................................................................................................................................... 9780 II.
Fentanyl ................................................................................................................................................................... 9801 II.
The company plans to manufacture DEPARTMENT OF JUSTICE Administration (DEA) as importers of
bulk controlled substances for use in various classes of schedule I or II
product development of analytical Drug Enforcement Administration controlled substances.
reference standards, for distribution to [Docket No. DEA–392] SUPPLEMENTARY INFORMATION:
its customers. The companies listed below applied
Dated: December 20, 2016. Importer of Controlled Substances to be registered as importers of various
Registration basic classes of controlled substances.
Louis J. Milione,
Assistant Administrator. ACTION: Notice of registration. Information on previously published
notices is listed in the table below. No
[FR Doc. 2016–31285 Filed 12–27–16; 8:45 am]
SUMMARY: Registrants listed below have comments or objections were submitted
BILLING CODE 4410–09–P
applied for and been granted and no requests for hearing were
registration by the Drug Enforcement submitted for these notices.
Company FR docket Published
Rhodes Technologies ........................................................... 81 FR 46956 ........................................................................ July 19, 2016.
Bellwyck Clinical Services .................................................... 81 FR 54603 ........................................................................ August 16, 2016.
Cerilliant Corporation ............................................................ 81 FR 57933 ........................................................................ August 24, 2016.
Noramco, Inc ........................................................................ 81 FR 57932 ........................................................................ August 24, 2016.
Cody Laboratories, Inc ......................................................... 81 FR 54602 ........................................................................ August 16, 2016.
AMRI Rensselaer, Inc .......................................................... 81 FR 54603 ........................................................................ August 16, 2016.
ALMAC Clinical Services Incorp (ACSI) .............................. 81 FR 54602 ........................................................................ August 16, 2016.
Fresenius Kabi USA, LLC .................................................... 81 FR 54601 ........................................................................ August 16, 2016.
Akorn, Inc ............................................................................. 81 FR 57935 ........................................................................ August 24, 2016.
Actavis Laboratories FL, Inc ................................................ 81 FR 54602 ........................................................................ August 16, 2016.
Unither Manufacturing LLC .................................................. 81 FR 61250 ........................................................................ September 6, 2016.
Cambrex Charles City .......................................................... 81 FR 63222 ........................................................................ September 14, 2016.
United States Pharmacopeial Convention ........................... 81 FR 63220 ........................................................................ September 14, 2016.
R & D Systems, Inc .............................................................. 81 FR 64509 ........................................................................ September 20, 2016.
Catalent CTS, LLC ............................................................... 81 FR 66081 ........................................................................ September 26, 2016.
The DEA has considered the factors in granted a registration as an importer for DATES: Registered bulk manufacturers of
21 U.S.C. 823, 952(a) and 958(a) and schedule I or II controlled substances to the affected basic classes, and
determined that the registration of the the above listed persons. applicants therefore, may file written
listed registrants to import the Dated: December 19, 2016. comments on or objections to the
applicable basic classes of schedule I or Louis J. Milione,
issuance of the proposed registration in
II controlled substances is consistent accordance with 21 CFR 1301.33(a) on
Assistant Administrator.
with the public interest and with United or before February 27, 2017.
[FR Doc. 2016–31273 Filed 12–27–16; 8:45 am]
States obligations under international
BILLING CODE 4410–09–P ADDRESSES: Written comments should
treaties, conventions, or protocols in
be sent to: Drug Enforcement
effect on May 1, 1971. The DEA
Administration, Attention: DEA Federal
investigated each company’s
DEPARTMENT OF JUSTICE Register Representative/DRW, 8701
maintenance of effective controls
Morrissette Drive, Springfield, Virginia
against diversion by inspecting and Drug Enforcement Administration 22152.
testing each company’s physical
sradovich on DSK3GMQ082PROD with NOTICES
security systems, verifying each [Docket No. DEA–392] SUPPLEMENTARY INFORMATION: The
company’s compliance with state and Attorney General has delegated her
local laws, and reviewing each Bulk Manufacturer of Controlled authority under the Controlled
company’s background and history. Substances Application: Johnson Substances Act to the Administrator of
Therefore, pursuant to 21 U.S.C. Matthey Inc. the Drug Enforcement Administration
952(a) and 958(a), and in accordance (DEA), 28 CFR 0.100(b). Authority to
ACTION: Notice of application.
with 21 CFR 1301.34, the DEA has exercise all necessary functions with
VerDate Sep<11>2014 18:54 Dec 27, 2016 Jkt 241001 PO 00000 Frm 00093 Fmt 4703 Sfmt 4703 E:\FR\FM\28DEN1.SGM 28DEN1](https://thefederalregister.org/doc/81_FR_95893/page/4.svg)
Document Created: 2016-12-28 02:17:02
Document Modified: 2016-12-28 02:17:02
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before February 27, 2017. | |
| FR Citation | 81 FR 95644 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR